Robert L Davidow sold $87k of ATXI
owner at AVENUE THERAPEUTICS, INC.. 617,000 shares at an average of $0.14, traded Dec 11, 2023, filed Dec 13, 2023.
Score components
- +12Role10% owner
- +9Trade size$87k at market
- +20Share of holdings soldSold 65% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +22.3%, 3m +18.7%, 6m -67.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001553350-23-000471, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 11, 2023 | SOpen-market sale Common Stock | -264,000 | $0.14 | $37k | 681,000 | Dec 13, 2023 |
| Dec 11, 2023 | SOpen-market sale Common Stockindirect: Joint account with spouse | -18,000 | $0.15 | $2,700 | 22,000 | Dec 13, 2023 |
| Dec 11, 2023 | SOpen-market sale Common Stockindirect: Trustee for Juliet Davidow 2001 Trust and Alexander Davidow 2010 Trust | -61,000 | $0.14 | $8,540 | 74,000 | Dec 13, 2023 |
| Dec 11, 2023 | SOpen-market sale Common Stockindirect: Shared investment and voting authority | -126,000 | $0.14 | $18k | 215,800 | Dec 13, 2023 |
| Dec 11, 2023 | SOpen-market sale Common Stockindirect: Shared investment authority | -128,000 | $0.14 | $18k | 147,000 | Dec 13, 2023 |
| Dec 11, 2023 | SOpen-market sale Common Stockindirect: By Spouse | -20,000 | $0.14 | $2,800 | 80,000 | Dec 13, 2023 |
Related signals
Other insiders at AVENUE THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | ATXIsell AVENUE THERAPEUTICS, INC. | Neil Herskowitz director | $46 23 shares | -19% | |
| 15Weak | ATXIsell AVENUE THERAPEUTICS, INC. | Jay D Kranzler director | $137 61 shares | -10% | |
| 33Weak | ATXIbuy AVENUE THERAPEUTICS, INC. | Jay D Kranzler director | $1,250 500 shares | +417% | |
| 57Moderate | ATXIsell AVENUE THERAPEUTICS, INC. | InvaGen Pharmaceuticals, Inc. owner | $3.0M 388,888 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.